Impairment of NKG2D-Mediated Tumor Immunity by TGF-β

Cited by (149)

Items 101–149 of 149

1. Echinococcus multilocularis induces surface high expression of inhibitory killer immunoglobulin‐like receptor on natural killer cells
   Bayindala, He Huang, Song Gao, Xinjian Xu · 2021 · Allergologia et Immunopathologia
2. Harnessing the power of memory-like NK cells to fight cancer
   Yun Yan Foo, Angelina Tiah, Shuh Wen Aung · 2023 · Clinical & Experimental Immunology
3. Arachidonic acid impairs natural killer cell functions by disrupting signaling pathways driven by activating receptors and reactive oxygen species
   Mohamad K. Hammoud, Celina Meena, Raimund Dietze, Nathalie Hoffmann, Witold Szymański, F. Finkernagel, Andrea Nist, Thorsten Stiewe, J. Graumann, E. P. von Strandmann et al. · 2024 · Cell Communication and Signaling
4. Hybrid regulatory T cells: camouflaged architects of tumor immunity
   Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, José Roberto Kfoury, Ephraim Abrokwa Ansa-Addo · 2025 · Frontiers in Immunology
5. Exploring the Tumor Microenvironment in Osteosarcoma: Driver of Resistance and Progression
   Aidan A. Schmidt, Advay Prasad, Alex R. Huisman, Mark R. Wakefield, Yujiang Fang · 2025 · Cancers
6. MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets
   Samuel Swearson, Aseel O. Rataan, Steven L. Eliason, Brad A. Amendt, Yousef Zakharia, Aliasger K. Salem, Thai H. Ho, Youcef M. Rustum · 2022 · International Journal of Molecular Sciences
7. Multifaceted nature of natural killer cells: Potential mode of interaction and shaping of stem cells
   Emanuela Senjor, Meng-Wei Ko, Kawaljit Kaur, Po-Chun Chen, Barbara Breznik, Nishant Chovatiya, Janko Kos, Anahid Jewett · 2023 · Elsevier eBooks
8. The prospects of microphysiological systems in modeling platelet pathophysiology in cancer
   Lopamudra D. Ghosh, Abhishek Jain · 2023 · Platelets
9. Developing a Safe and Effective CAR T-Cell Immunotherapy for Breast Cancer: Progress and Pitfalls
   Pierre Antoine, John F. Maher · 2020 · Breast Cancer Management
10. Harnessing natural killer cells to develop next‐generation cellular immunotherapy
    Siyao Liu, Kaycee Nguyen, Dongyong Park, Nelson Wong, Anson Wang, Yubin Zhou · 2022 · Chronic Diseases and Translational Medicine
11. STAT1 is associated with NK cell dysfunction by downregulating NKG2D transcription in chronic HBV-infected patients
    Xiaojuan Huang, Qiong Mo, Tao Fu, Yueping Liu, Bo Diao · 2022 · Immunobiology
12. Discovery and preclinical evaluation of BPB-101: a novel triple functional bispecific antibody targeting GARP-TGF-β complex/SLC, free TGF-β and PD-L1
    Wenxin Xu, Jieying Xu, Pingcui Li, Deyu Xu, Hongjie Cheng, Huan Zheng, Li Zhang, Mengmeng Liu, Siyuan Ye, Mengshi Jiang et al. · 2024 · Frontiers in Immunology
13. IL-15 complex enhances therapeutic efficacy of anti-PD-L1 in a T cell–dependent and NK cell–independent manner in a murine model of pancreatic ductal adenocarcinoma
    Adam L. Burrack, Alexander K. Tsai, Madeline A. Ellefson, Zoe C. Schmiechen, Brandon M. Larsen, Kristina S. Burrack, Ingunn M. Stromnes · 2025 · The Journal of Immunology
14. OV Modulators of the Paediatric Brain TIME: Current Status, Combination Strategies, Limitations and Future Directions
    Konstantinos Vazaios, Ronja E. van Berkum, Friso Calkoen, Jasper van der Lugt, Esther Hulleman · 2024 · International Journal of Molecular Sciences
15. Ca:Mg D, the Shield that Interdicts the Crown Viruses and Vaccines
    Patrick William Chambers · 2022 · OALib
16. Natural killer cell dysfunction in glioma: from immune evasion to immunotherapy
    Run Zhang, Pengcheng Ma, Ke Tang, Yanchun Cao, Yani Yang, Shengyang Hao, Tingting Li, Xiaoming Peng · 2026 · Frontiers in Immunology
17. Reprogramming Antitumor Immunity: NK Cell Strategies to Navigate the Immunosuppressive Tumor Microenvironment
    Tereza Kochs, Pranay Nath, Alice J Chen, Rizwan Romee, Andreia Maia · 2026 · Advanced Science
18. Pathological Mechanisms Involved in HIV-Associated Lymphomagenesis: Novel Targeted Therapeutic Approaches
    Mihaela Straistă, Francesca Caccuri, Nicoleta Arnaut, Arnaldo Caruso, MARK A. SLEVIN · 2025 · Cells
19. RAE1-armoured DC vaccine boosts NKG2D-CAR-T cells elicited anti-solid tumour treatment
    Yixin Duan, Weirong Zhan, Jie Yao, Li Zhang, Yujia Ge, Ying Yin Zhou, Yaoxin Gao, Dandan Guo, Bingtan Du, Lijun Wang et al. · 2025 · Pharmacological Research
20. Biodegradable Nanomissile Targeting the NKG2D/NKG2DL Axis Boosts Photo‐Immunotherapy by T Cell plus NK Cell Attack
    Ling Lin, Guimei Chen, Zhongshu Pan, Zinian Zhu, Xiaoying Li, Siyi Yang, Bingchen Zhang, Yuanyuan Yang, Jiasi Zhang, Zhiqiang Yu et al. · 2026 · Advanced Functional Materials
21. NKG2D CAR-T cells for solid tumor immunotherapy: advances, challenges, and future directions
    Chen Liu, Zhiqiang Wang, Wentao Zhang, Guangping Cheng, Siyan Cheng, Long Qin, Huili Ye, Wen Ren · 2026 · Frontiers in Immunology
22. Macrophage plasticity in the osteosarcoma tumor microenvironment: opportunities and challenges for immunotherapy
    Haifeng Li, Chengri Liu, Baojian Zhang, Yanhu Zhang, Yanqun Liu · 2026 · Journal of Cancer Research and Clinical Oncology
23. Role of innate immunity in the development of cancer immunotherapy immune-mediated adverse events
    Álvaro Sierra-Salazar, Yatzil Reyna-Juárez, Beatriz Alcalá‐Carmona, Rodrigo Quintana-Tenorio, Jennifer Tiaré Balderas-Miranda, Johan Camacho-Pérez, Jiram José Torres-Ruiz · 2026 · Frontiers in Immunology
24. Immunotherapy in pediatric bone sarcomas: Current progress and future directions
    Rachel Weil, David Mark Loeb · 2026 · Human Vaccines & Immunotherapeutics
25. Reversing the NK inhibitory tumor microenvironment by targeting suppressive immune effectors
    Ishwar Navin, Robin Parihar · 2023 · Elsevier eBooks
26. Red–Blue Light Therapy Mitigates Atopic Dermatitis via CD56bright NK Cell Modulation: A Mendelian Randomization Study
    Jielin Zhang, Teng Yu, Xiaowen Wen, Jing Wu, Suitian Wang, Xuening Ma · 2025 · Photodermatology Photoimmunology & Photomedicine
27. Potential strategies to improve the therapeutic efficacy of oncolytic viruses for cancer through T and NK cells targeting
    Chuanjian Wu, Hanzhang Liu, Yujie Shi, Jie Tang, Rong Sun, Xudong Han, Yihui Fan · 2025 · Critical Reviews in Oncology/Hematology
28. Unlocking the potential: current landscape and future directions of immunotherapy in gastric cancer
    Yingfei Zhou, Luling Wei, Luoyang Wang, Bei Zhang, Jie Liang · 2026 · Frontiers in Immunology
29. The dual role of Natural Killer cells during tumor progression and angiogenesis: Implications for tumor microenvironment-targeted immunotherapies
    Lorenzo Mortara, Denisa Baci, Grace Coco, Alessandro Delli Poggi, Antonino Bruno · 2021 · Elsevier eBooks
30. Biology of NK Cells and NK Cells in Clinic
    Grace Caroline Birch, Todd A. Fehniger, Rizwan Romee · 2022 · Cancer drug discovery and develogment/Cancer drug discovery and development
31. Transforming cancer immunotherapy: Overcoming immunosuppression in tumors via gene silencing techniques based on nanoparticles
    Pranoy Saha, Md.Ashrarul Hasib, Babette Halder, Surovi Sultana, Md. Rajdoula Rafe · 2024 · Journal of Drug Delivery Science and Technology
32. Checkpoint inhibition in the fight against cancer: NK cells have some to say in it
    Christian Sordo‐Bahamonde, Seila Lorenzo‐Herrero, Ana Pilar González, Segundo R. Gonzalez · 2021 · Elsevier eBooks
33. The role of TGF-β pathway alterations in immune regulation as a potential pan-cancer biomarker in immunotherapy
    Yan Liang, Wěi Li, Bing Qian, Jie Ming, Zhengyi Zhao, Zhengqing Yan, Xiaochen Zhao, Shiqing Chen, Yongmei Yin · 2021 · Annals of Translational Medicine
34. 311 Disruption of TGF-b signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells
    Jaya Lakshmi Thangaraj, Michael Coffey, Dan S. Kaufman · 2023 · Regular and Young Investigator Award Abstracts
35. Characterisation of distinct senescent-like T cell populations during healthy and unhealthy ageing
    Conor Garrod-Ketchely, Lauren A. Callender, Johannes Schroth, Katie Littlewood, Elizabeth C. Carroll, Dina Tamsan, Victoria Tsang, Isabell Nessel, Natalie E. Riddell, Benny Chain et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
36. Estudio celular de la inmunosenescencia en adultos mayores vacunados y en pacientes con cáncer de mama
    Rodríguez Rodríguez, Ivon Johanna · 2021
37. Evaluation of Natural killer activated receptor NKG2D, Inhibitory receptor KIR2DL1 and soluble ligand MICA in Iraqi patients of Acute myeloid leukemia
    Baan Abdulatif Mtashar, Zainab Fadhel Ashoor, Zeyad Ahmed Shabeeb, Bassam Francis Matti · 2022 · Journal of Pharmaceutical Negative Results
38. Research progress on the correlation between platelet aggregation and tumor progression.
    Yuyu Chen, Jialong Yuan, Faqing Tang, Qinglin Liu, Hongjun Huang, Huan Liu, Hao Liu · 2024 · PubMed
39. A conserved subset of cold tumors responsive to immune checkpoint blockade
    Jade Moore, Jim Gkantalis, Inés Guix, William S. Chou, Kobe Chi Yung Yuen, Ann A. Lazar, Mathew Spitzer, Alexis J. Combes, Mary Helen Barcellos‐Hoff · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
40. Altération du métabolisme et des fonctions des cellules Natural Killer dans la leucémie aigüe myéloïde : rôle de la signalisation IL-15
    Berna Bou‐Tayeh · 2020
41. The Elovl5 enzyme in breast cancer : regulation of cancer cell proliferation and metastasis
    Trinh‐Le‐Vi Kieu · 2021 · theses.fr (ABES)
42. Expansions de NK et Lymphocytes T gamma delta comme outil thérapeutique post-allogreffe dans la Leucémie Aigue Myeloide
    Nassim Salem · 2023 · theses.fr (ABES)
43. Unraveling the Multifaceted Landscape of the Tumor Microenvironment through Mechanistic Insights and Therapeutic Frontiers
    Depanshi Pandit, Parul Sharma · 2026 · Mini-Reviews in Medicinal Chemistry
44. Regulatory T Cells: A Critical Factor in the Development and Progression of Hepatocellular Carcinoma
    慶春 沈 · 2026 · Advances in Clinical Medicine
45. Breast cancer stem cells across subtypes: Biology, challenges, and recent advances
    Hina Qayoom, Rumaisa Khan, Arfa Ji, Ayesha Jabeen, M Farooq Mir · 2026 · Elsevier eBooks
46. Advances and challenges in immunotherapy for intrahepatic cholangiocarcinoma based on the tumour immune microenvironment
    Mengyao Chen, Shuofan Jin, Yuxuan Zhou, Jinkai Tong, Yufan Zhao, Quanjun Yang · 2026 · Clinical and Translational Medicine
47. IL-15 trans-presentation at the innate-adaptive interface: mechanisms and translation in cancer immunotherapy
    Corey Keith Goldman · 2026 · OncoImmunology
48. Antigen-experienced NK-T cells: integrating new insights and exploring therapeutic potential in cancer immunotherapy
    Shunichiro Kuramitsu, Masasuke Ohno, Mitsugu Fujita · 2026 · Frontiers in Immunology
49. PTPN22 as a novel therapeutic target: a key intracellular checkpoint for NK cell therapy
    Tung Nguyen Thanh Uong, Mee Sun Yoon, Nhat Phuoc Nguong Minh Nguyen, Mijeong Lee, Seung Kwon Koh, Jae‐Uk Jeong, Yong-Hyub Kim, Duck Cho · 2026 · Journal for ImmunoTherapy of Cancer